Cargando…
STUDIES ON ANTIBLASTIC IMMUNITY
Antipneumococcus serum under certain conditions apparently inhibits or retards the metabolic activities of the homologous pneumococcus. Antipneumococcus serum exhausted of its agglutinin content possesses no inhibitory properties. The degree of inhibitory action of antipneumococcus serum parallels i...
Autor principal: | Blake, Francis G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1917
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2125789/ https://www.ncbi.nlm.nih.gov/pubmed/19868167 |
Ejemplares similares
-
ANTIBLASTIC IMMUNITY
por: Dochez, A. R., et al.
Publicado: (1916) -
ANTIBLASTIC PHENOMENA IN ACTIVE ACQUIRED IMMUNITY AND IN NATURAL IMMUNITY TO PNEUMOCOCCUS
por: Barber, M. A.
Publicado: (1919) -
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019) -
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection
por: Fazzini, Luca, et al.
Publicado: (2022) -
Animal Models in Studies of Cardiotoxicity Side Effects from Antiblastic Drugs in Patients and Occupational Exposed Workers
por: Lamberti, Monica, et al.
Publicado: (2014)